Justin’s Story: Living with Duchenne Muscular Dystrophy
January 23, 2025
When Justin was first diagnosed with Duchenne muscular dystrophy, his parents, Amanda and Andrew, weren’t sure how to navigate the challenges ahead. After partnering with Anovo, they’ve found the support they need to manage the complexities of Justin’s care. Watch the video to learn how Anovo’s Care Coordinators help with insurance coordination and ensure timely therapy, giving Amanda and Andrew more time to focus on what matters most—Justin’s well-being.
“I definitely feel like we’re getting a personal connection with Anovo. They reach out and make sure my son is getting the best quality of everything they offer.”
Related Posts
How Anovo Builds Dedicated Teams to Support Your Rare Disease Therapy
At Anovo, we understand that complex rare disease therapies require high-touch service that large payer- and Pharmacy Benefit Manager-owned Specialty…
January 24, 2025
Eton Pharmaceuticals & Anovo Partner to Expand Access for Patients with Severe Primary Insulin-Like Growth Factor 1 Deficiency
Eton Pharmaceuticals is dedicated to developing and commercializing treatments for rare diseases, with a strong focus on pediatric endocrinology. Their…
January 23, 2025
Supporting Innovative ALS Treatments with Clene Nanomedicine & Synapticure
Anovo is proud to announce a new partnership with Clene Nanomedicine, Inc. and Synapticure Inc., supporting their efforts to bring…
January 23, 2025
